Interestingly, though the decrease in risk of infection with CPZ (a first-generation antipsychotic) was not quite statistically significant, none of the 47 COVID-19 infected patients taking CPZ died of COVID-19 related causes.
← all excerpts
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters.
1
—
—